Skip to main content
Erschienen in: Supportive Care in Cancer 2/2015

01.02.2015 | Original Article

Re-examining the factor structure and psychometric properties of the Mini-Mental Adjustment to Cancer Scale in a sample of 364 Chinese cancer patients

verfasst von: Ted C. T. Fong, Rainbow T. H. Ho

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Mini-Mental Adjustment to Cancer Scale (Mini-MAC) is widely used to evaluate cancer patients’ psychological responses. Validation studies of the scale have shown methodological shortcomings and inconsistency in the factor solutions. The aim of this study was to examine the factor structure and psychometric properties of the Mini-MAC.

Methods

A large sample of 364 Chinese patients with breast or colorectal cancer completed the Mini-MAC and psychosocial measures (general health, perceived stress, anxiety, and depression). Exploratory factor analyses examined the relative fit of two- to six-factor models using robust weighted least square estimation and oblique target rotation. Convergent validity was evaluated via correlations between the Mini-MAC factor scores and the psychosocial outcomes.

Results

The five-factor model showed the best model fit and largely replicated the original Mini-MAC’s helpless/hopeless (HH), anxious preoccupation (AP), fighting spirit (FS), fatalism (FA), and cognitive avoidance (CA) subscales. The five factors had acceptable reliability (Cronbach’s α = 0.67–0.88) and 4-month test-retest reliability (r = 0.45–0.64). HH, AP, and CA were positively associated with the psychosocial outcomes (r = 0.19–0.60). Modest and negative correlations were found between the psychosocial outcomes and FS and FA.

Conclusions

The results support the Mini-MAC’s original five-factor structure with satisfactory reliability and convergent validity. The results demonstrate that the Mini-MAC is a valid measure for assessing psychological responses in cancer patients.
Literatur
3.
Zurück zum Zitat Johansson M, Ryden A, Finizia C (2011) Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - A longitudinal study. Bmc Cancer 11. doi:10.1186/1471-2407-11-283 Johansson M, Ryden A, Finizia C (2011) Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - A longitudinal study. Bmc Cancer 11. doi:10.​1186/​1471-2407-11-283
4.
Zurück zum Zitat Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B (1988) Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 18(1):203–209PubMedCrossRef Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B (1988) Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 18(1):203–209PubMedCrossRef
5.
Zurück zum Zitat Watson M, Law M, Dossantos M, Greer S, Baruch J, Bliss J (1994) The Mini-MAC—further development of the Mental Adjustment to Cancer Scale. J Psychosoc Oncol 12(3):33–46. doi:10.1300/j077v12n03_03 CrossRef Watson M, Law M, Dossantos M, Greer S, Baruch J, Bliss J (1994) The Mini-MAC—further development of the Mental Adjustment to Cancer Scale. J Psychosoc Oncol 12(3):33–46. doi:10.​1300/​j077v12n03_​03 CrossRef
6.
Zurück zum Zitat Ho SMY, Fung WK, Chan CLW, Watson M, Tsui YKY (2003) Psychometric properties of the Chinese version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology 12(6):547–556. doi:10.1002/pon.672 PubMedCrossRef Ho SMY, Fung WK, Chan CLW, Watson M, Tsui YKY (2003) Psychometric properties of the Chinese version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology 12(6):547–556. doi:10.​1002/​pon.​672 PubMedCrossRef
7.
Zurück zum Zitat Grassi L, Buda P, Cavana L, Annunziata MA, Torta R, Varetto A (2005) Styles of coping with cancer: the Italian version of the mini-mental adjustment to cancer (Mini-MAC) scale. Psychooncology 14(2):115–124. doi:10.1002/pon.826 PubMedCrossRef Grassi L, Buda P, Cavana L, Annunziata MA, Torta R, Varetto A (2005) Styles of coping with cancer: the Italian version of the mini-mental adjustment to cancer (Mini-MAC) scale. Psychooncology 14(2):115–124. doi:10.​1002/​pon.​826 PubMedCrossRef
8.
Zurück zum Zitat Anagnostopoulos F, Kolokotroni P, Spanea E, Chryssochoou M (2006) The mini-mental adjustment to cancer (Mini-MAC) scale: Construct validation with a Greek sample of breast cancer patients. Psychooncology 15(1):79–89. doi:10.1002/pon.924 PubMedCrossRef Anagnostopoulos F, Kolokotroni P, Spanea E, Chryssochoou M (2006) The mini-mental adjustment to cancer (Mini-MAC) scale: Construct validation with a Greek sample of breast cancer patients. Psychooncology 15(1):79–89. doi:10.​1002/​pon.​924 PubMedCrossRef
9.
Zurück zum Zitat Kang JI, Chung HC, Kim SJ, Choi HJ, Ahn JB, Jeung HC, Namkoong K (2008) Standardization of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) scale: Factor structure, reliability and validity. Psychooncology 17(6):592–597. doi:10.1002/pon.1277 PubMedCrossRef Kang JI, Chung HC, Kim SJ, Choi HJ, Ahn JB, Jeung HC, Namkoong K (2008) Standardization of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) scale: Factor structure, reliability and validity. Psychooncology 17(6):592–597. doi:10.​1002/​pon.​1277 PubMedCrossRef
10.
11.
Zurück zum Zitat Costello AB, Osborne JW (2005) Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval 10(7):1–9 Costello AB, Osborne JW (2005) Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval 10(7):1–9
13.
Zurück zum Zitat Hulbert-Williams NJ, Hulbert-Williams L, Morrison V, Neal RD, Wilkinson C (2012) The Mini-Mental Adjustment to Cancer Scale: Reanalysis of its psychometric properties in a sample of 160 mixed cancer patients. Psychooncology 21(7):792–797. doi:10.1002/pon.1994 PubMedCrossRef Hulbert-Williams NJ, Hulbert-Williams L, Morrison V, Neal RD, Wilkinson C (2012) The Mini-Mental Adjustment to Cancer Scale: Reanalysis of its psychometric properties in a sample of 160 mixed cancer patients. Psychooncology 21(7):792–797. doi:10.​1002/​pon.​1994 PubMedCrossRef
14.
Zurück zum Zitat Pan PC, Goldberg D (1990) A comparison of the validity of GHQ-12 and CHQ-12 in Chinese primary care patients in Manchester. Psychol Med 20(4):931–940PubMedCrossRef Pan PC, Goldberg D (1990) A comparison of the validity of GHQ-12 and CHQ-12 in Chinese primary care patients in Manchester. Psychol Med 20(4):931–940PubMedCrossRef
16.
Zurück zum Zitat Fong TCT, Ho RTH (2013) Factor analyses of the hospital anxiety and depression scale: a Bayesian structural equation modeling approach. Qual Life Res:1–7. doi:10.1007/s11136-013-0429-2 Fong TCT, Ho RTH (2013) Factor analyses of the hospital anxiety and depression scale: a Bayesian structural equation modeling approach. Qual Life Res:1–7. doi:10.​1007/​s11136-013-0429-2
17.
Zurück zum Zitat Muthén LK, Muthén B (1998–2013) Mplus user’s guide. 7th edn. Muthen & Muthen, Los Angeles, CA Muthén LK, Muthén B (1998–2013) Mplus user’s guide. 7th edn. Muthen & Muthen, Los Angeles, CA
18.
22.
Zurück zum Zitat Fitzpatrick C, Levine EG, Heide F, Zelman D, Targ E (2000) Re-examining the construct of fatalism in women with breast cancer: Stoic resignation versus spiritually-focused acceptance. Psychooncology 9(5):S90 Fitzpatrick C, Levine EG, Heide F, Zelman D, Targ E (2000) Re-examining the construct of fatalism in women with breast cancer: Stoic resignation versus spiritually-focused acceptance. Psychooncology 9(5):S90
Metadaten
Titel
Re-examining the factor structure and psychometric properties of the Mini-Mental Adjustment to Cancer Scale in a sample of 364 Chinese cancer patients
verfasst von
Ted C. T. Fong
Rainbow T. H. Ho
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2367-0

Weitere Artikel der Ausgabe 2/2015

Supportive Care in Cancer 2/2015 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.